Proteinuria in Liver Transplantation, a Single Egyptian Center Study

NCT05733754 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-02-17

No results posted yet for this study

Summary

Proteinuria has been suggested to be a predictive factor and an important tool for differentiating the etiology of renal dysfunction in various clinical scenarios .The good predictive performance of preoperative proteinuria utilized for the development of renal failure after operation has been reported . In the literature, prognostic significance of several scoring systems for end-stage liver disease has been validated . The Sequential Organ Failure Assessment (SOFA) system was found to be superior to ChildPugh points (CP points) and Model for End-Stage Liver Disease (MELD) score, and postoperative day 7 SOFA had the best discriminative power for predicting 3-month and 1-year mortality after liver transplantation . Renal dysfunction is one of the most significant adverse events in patients awaiting or undergoing a liver transplant, and its occurrence generally indicates a high rate of poor prognosis

Conditions

  • Liver Transplant; Complications

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • marwa m abokrsha, MD · Lecturerer of internal medicine Gastroenterology and hepatology

  • Ramy A Hassan, Md · Assistant professor of surgery

  • Ahmed m Taha, MD · Assistant professor of surgery

  • Lobna A Ahmed, MD · Professor of internal medicine Gastroenterology and hepatology

  • Reem E Mahdy, MD · Consultant of internal medicine and hepatology

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2023-10-31
Completion
2024-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05733754 on ClinicalTrials.gov